Skip to main content

news

 

U.S. law firm Latham & Watkins and the PRC’s Dahui Lawyers have advised Asian courier service group J&T Global Express on its $501 million initial public offering on the Hong Kong Stock Exchange (HKEX),  the second-largest listing on the bourse this year.

New York-headquartered Skadden, Arps, Slate, Meagher & Flom advised the underwriters led by Morgan Stanley, BofA Securities and China International Capital Corp on Hong Kong and US law. PRC advisory to the underwriters was provided by Han Kun Law Offices and Commerce & Finance Law Offices.

Tencent-backed J&T Global was also guided by a string of firms in Southeast Asia on local compliance issues across the region. Hutabarat Halim & Rekan in Indonesia, Vilaf in Vietnam, Rahmat Lim & Partners in Malaysia, SyCip Salazar Hernandez & Gatmaitan in the Philippines, and Weerawong, Chinnavat & Partners in Thailand advised on the IPO.

The Skadden team advising the underwriters was led by partners Haiping Li (Hong Kong/Shanghai), Paloma Wang (Hong Kong) and Yuting Wu (Shanghai).

The Latham team was led by Hong Kong corporate partners Frank Sun, Benjamin Su, Terris Tang and Cathy Yeung, with tax advice provided by New York partner Bora Bozkurt.  

J&T Global will use the gross proceeds to develop logistics networks and warehouse capacity in Southeast Asia, expand to new markets and fund research and development, among other uses.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Paul Hastings, Latham lead on $827 mln LG CNS Korea IPO

Paul Hastings has advised South Korean tech services firm and LG Group member company LG CNS on its 1.2-trillion-won ($827 million) global offering and listing on the Korea Exchange, with Latham & Watkins advising the bookrunners.

SAM, Khaitan act on WeWork India’s upcoming $460 mln IPO

by Nimitt Dixit |

Shardul Amarchand Mangaldas is advising WeWork India, the Indian franchisee of U.S. shared office space manager WeWork, on its upcoming initial public offering (IPO) valued at $460 million.

MoFo, Ropes, Mori Hamada guide Bain's $3.3 bln Mitsubishi Pharma buyout

by Nimitt Dixit |

Morrison Foerster, Mori, Hamada & Matsumoto, and Ropes & Gray have advised U.S. investment fund Bain Capital on its planned 510-billion-yen ($3.3 billion) acquisition of Mitsubishi Tanabe Pharma Corporation from Mitsubishi Chemical Group Corporation.